Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.

MLA

Kwan, Angela T. H., et al. “Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.” Annals of General Psychiatry, vol. 23, no. 1, Feb. 2024, p. 10. EBSCOhost, https://doi.org/10.1186/s12991-024-00494-1.

APA

Kwan, A. T. H., Le, G. H., Guo, Z., Ceban, F., Teopiz, K. M., Rhee, T. G., Ho, R., Di Vincenzo, J. D., Badulescu, S., Meshkat, S., Cao, B., Rosenblat, J. D., Dev, D. A., Phan, L., Subramaniapillai, M., & McIntyre, R. S. (2024). Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine. Annals of General Psychiatry, 23(1), 10. https://doi.org/10.1186/s12991-024-00494-1

Chicago

Kwan, Angela T H, Gia Han Le, Ziji Guo, Felicia Ceban, Kayla M Teopiz, Taeho Greg Rhee, Roger Ho, et al. 2024. “Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.” Annals of General Psychiatry 23 (1): 10. doi:10.1186/s12991-024-00494-1.